What Doctors Don't Tell YouI have had hepatitis C for 26 years and, recently, have been under great pressure from my hospital doctors to agree to combined inteferon/ribavirin treatment. I have refused, suspecting that this therapy is dangerous and unproven.
Coincidentally, this week the Glasgow Herald ran an article about a woman whose eyesight had been damaged by combination therapy. I then found an article from the American journal The Hepatologist, saying that neurovisual damage is a frequent side-effect of interferon.
Now, I know that doctors don’t use words like ‘frequent’ carelessly, but you won’t find this possible side-effect in any patient literature, and hospital doctors certainly don’t tell you about this possibility.
My concern is that pegylated interferon/ ribavirin is being forced upon hepaitits C patients all over the country. We are threatened, coerced and intimidated with descriptions of end-stage liver disease if we resist. Yet, the overall ‘success’ rate (over all types of hepatitis C) is only 20 per cent – in other words, a failure rate of 80 per cent.
Patients are usually put on the combination therapy for six months or a year. The side-effects are often severe, despite the reassuring propaganda from the hospitals and drug companies. There have been numerous suicides, as combination therapy can cause serious depression and even psychosis. Again, this is never mentioned in patients’ literature. The hospital consultants’ solution is to offer antidepressants as well as the combination therapy.
I have been unable to discover any statistics for side-effects, but I know people who have taken the treatment and been left with diabetes, arthritis, deafness or resumption of bleeding years after the menopause. When the girlfriend of a young man taking combination therapy became pregnant, she had to abort her baby because ribavirin causes birth defects. But no one has answered the main question: is there any evidence that this bombardment with chemotherapy has any significant effect on life expectancy compared with letting the disease take its own course?
Essentially, people with hepatitis C are guinea pigs for a nationwide drugs trial; reputations and fortunes to be made in this gold rush. Hepatitis C is a huge and growing problem, and my worry is that the already fragile health of thousands of vulnerable people is being undermined still further. – SB, Glasgow
Daniel Redwood DC
Tom Ferguson MD
